Product Certification&
    Enterprise Certification

  • Mr.Jack Shen
    Tel: +86-571-86758373

  • Mobile:+8613588754946
  • Tel:+86-571-86758373
  • Fax:
  • URL:http://www.huarongpharm.com
  • Province/state:Zhejiang
  • City:Hangzhou
  • Street:Room1101, Hakim International Building, Gongshu District, Hangzhou, Zhejiang Province, China.
  • MaxCard:
Home > Products >  Hydrocortisone Sodium Succinate

Hydrocortisone Sodium Succinate CAS NO.125-04-2

  • FOB Price: USD: 1.00-2.00 /Gram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T
  • Available Specifications:

    99% (1-2)Gram99% (2-5)Gram99.9%(1-2)Gram

  • Product Details

Keywords

  • 125-04-2
  • Hydrocortisone Sodium Succinate
  • Hydrocortisone Sodium

Quick Details

  • ProName: Hydrocortisone Sodium Succinate
  • CasNo: 125-04-2
  • Molecular Formula: C25H33O8.Na
  • Appearance: Off-White Powder
  • Application: A relatively potent non-narcotic, nons...
  • DeliveryTime: 20 day
  • PackAge: Aluminium bag & Paper Drum
  • Port: Shanghai
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: Normal temperature
  • Transportation: Normal condition
  • LimitNum: 1 Kilogram
  • Related Substances: Less than 1.0%
  • Residue on Ignition: Less than 0.1%
  • Heavy Metal: 20 ppm
  • Valid Period: 24 months
  • DMF: Available

Superiority

DMF is available.

 

 

Huarong Industrial Group Limited established since 2006 , has been actively developing specialty products for Finished Dosages, APIs, Intermediates, and Fine chemicals markets in North America, Europe, Korea, Japan, Mid-East and all over the World.

 

Huarong Group has a team of more than 15 professionals working with diligence and tenacity at all hours trying to make a breakthrough and leap to the industry and yours. In addition to the distribution, Huarong people have invested in Lab and cGMP plants to allows us to offer service like: develop non-infringing synthesis process(include impurity study, stability study novel polymorph forms,ect) ,technology transfer, with a view to the long-term supply to support FTF In US, EU, China and other markets.


Huarong people has built our success through the success of our clients by providing complete solutions. As our belief to be your “China Business Partner & Solution", we are looking forward to establishing a long term cooperation with our partners and clients all over the world.

Details

 DMF is available.

 

 

Huarong Industrial Group Limited established since 2006 , has been actively developing specialty products for Finished Dosages, APIs, Intermediates, and Fine chemicals markets in North America, Europe, Korea, Japan, Mid-East and all over the World.

 

Huarong Group has a team of more than 15 professionals working with diligence and tenacity at all hours trying to make a breakthrough and leap to the industry and yours. In addition to the distribution, Huarong people have invested in Lab and cGMP plants to allows us to offer service like: develop non-infringing synthesis process(include impurity study, stability study novel polymorph forms,ect) ,technology transfer, with a view to the long-term supply to support FTF In US, EU, China and other markets.


Huarong people has built our success through the success of our clients by providing complete solutions. As our belief to be your “China Business Partner & Solution", we are looking forward to establishing a long term cooperation with our partners and clients all over the world.

 

In the United States, flunixin meglumine is approved for use in horses, cattle and swine; however, it is approved for use in dogs in other countries. The approved indications for its use in the horse are for the alleviation of inflammation and pain associated with musculoskeletal disorders and alleviation of visceral pain associated with colic. In cattle it is approved for the control of pyrexia associated with bovine respiratory disease and endotoxemia, and control of inflammation in endotoxemia. In swine, flunixin is approved for use to control pyrexia associated with swine respiratory disease.
Flunixin has been suggested for many other indications in various species, including: Horses: foal diarrheas, shock, colitis, respiratory disease, post-race treatment, and pre- and post ophthalmic and general surgery; Dogs: disk problems, arthritis, heat stroke, diarrhea, shock, ophthalmic inflammatory conditions, pre- and post ophthalmic and general surgery, and treatment of parvovirus infection; Cattle: acute respiratory disease, acute coliform mastitis with endotoxic shock, pain (downer cow), and calf diarrheas; Swine: agalactia/hypogalactia, lameness, and piglet diarrhea. It should be noted that the evidence supporting some of these indications is equivocal and flunixin may not be appropriate for every case.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog